Jiangsu Jibeier Pharmaceutical Co., Ltd.

Shanghai Stock Exchange 688566.SS

Jiangsu Jibeier Pharmaceutical Co., Ltd. Market Capitalization on January 27, 2025: USD 611.82 M

Jiangsu Jibeier Pharmaceutical Co., Ltd. Market Capitalization is USD 611.82 M on January 27, 2025, a -7.22% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.
  • Jiangsu Jibeier Pharmaceutical Co., Ltd. 52-week high Market Capitalization is USD 760.57 M on May 08, 2024, which is 24.31% above the current Market Capitalization.
  • Jiangsu Jibeier Pharmaceutical Co., Ltd. 52-week low Market Capitalization is USD 487.65 M on February 05, 2024, which is -20.30% below the current Market Capitalization.
  • Jiangsu Jibeier Pharmaceutical Co., Ltd. average Market Capitalization for the last 52 weeks is USD 625.00 M.
Key data
Date Market Capitalization Share Price Price to Earnings Ratio (P/E) Price to Sales Ratio (P/S)
Market news
SV Wall Street
Shanghai Stock Exchange: 688566.SS

Jiangsu Jibeier Pharmaceutical Co., Ltd.

CEO Mr. Zhongyi Geng
IPO Date May 18, 2020
Location China
Headquarters High-tech Industrial Development Zone
Employees 1,445
Sector Healthcare
Industries
Pharmaceuticals Biotechnology
Description

Jiangsu Jibeier Pharmaceutical Co., Ltd., a pharmaceutical company, engages in the research, development, production, and sale of chemical preparations, proprietary Chinese medicine preparations, and bulk medicines. The company's products cover various therapeutic areas, such as improving white blood cells, enhancing immunity, treating joint diseases, anti-hypertension, anti-eye infections, treating bronchitis, protecting liver function, etc. It is also developing drugs for the treatment of depression, tumors, stomach diseases, and other diseases. The company was founded in 2001 and is based in Zhenjiang, China.

StockViz Staff

February 2, 2025

Any question? Send us an email